CERN Scientific Advisor Shares Support for Childhood Cancer Awareness Month
By David Arons
CEO of the National Brain Tumor Society
In the brain tumor community, Childhood Cancer Awareness Month has a particular significance and importance. Indeed, pediatric brain tumors are the second-most common cancer in children (ages 0-14); most prevalent across the entire pediatric spectrum (0-19); and have unfortunately surpassed leukemia as the deadliest of all childhood and adolescent cancers, now accounting for three out of every 10 cancer deaths in our nation’s youth.
All pediatric brain tumors — including medulloblastoma, juvenile pilocytic astrocytomas, AT/RT, ependymoma, and others — are serious and potentially life-threatening and life-altering diseases for which more attention should be given and more must be done. Current treatment for many of these tumor types often simply relies on radiation – which can have potentially devastating late-effect on a child’s developing, and vulnerable, brain.